Lipopolysaccharide induces neovascularization and immunosuppression, and must be considered as therapentic target

dc.contributor.author	Sydorchuk, L.
dc.contributor.author	Fomin, P.
dc.contributor.author	Sydorchuk, R.
dc.contributor.author	Sydorchuk, I.
dc.contributor.author	Plehutsa, O.
dc.contributor.author	Sydorchuk, A.
dc.date.accessioned	2014-05-06T05:06:29Z
dc.date.available	2014-05-06T05:06:29Z
dc.date.issued	2013
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/7392
dc.language.iso	en	ru_RU
dc.publisher	«Targeted Therapies in Hepatologu» Worshop.- Abstract Book (Hannover, Germany, January 24-25, 2013). – P.36.	ru_RU
dc.title	Lipopolysaccharide induces neovascularization and immunosuppression, and must be considered as therapentic target	ru_RU
dc.type	Thesis	ru_RU